Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
DDX3X: structure, physiologic functions and cancer
J Mo, H Liang, C Su, P Li, J Chen, B Zhang - Molecular cancer, 2021 - Springer
The DEAD-box helicase family member DDX3X (DBX, DDX3) functions in nearly all stages
of RNA metabolism and participates in the progression of many diseases, including virus …
of RNA metabolism and participates in the progression of many diseases, including virus …
Advances in the management of peritoneal malignancies
Peritoneal surface malignancies (PSMs) are usually associated with a poor prognosis.
Nonetheless, in line with advances in the management of most abdominopelvic metastatic …
Nonetheless, in line with advances in the management of most abdominopelvic metastatic …
An algorithmic immunohistochemical approach to define tumor type and assign site of origin
AM Bellizzi - Advances in anatomic pathology, 2020 - journals.lww.com
Immunohistochemistry represents an indispensable complement to an epidemiology and
morphology-driven approach to tumor diagnosis and site of origin assignment. This review …
morphology-driven approach to tumor diagnosis and site of origin assignment. This review …
BAP1 haploinsufficiency predicts a distinct immunogenic class of malignant peritoneal mesothelioma
Abstract Background Malignant peritoneal mesothelioma (PeM) is a rare and fatal cancer
that originates from the peritoneal lining of the abdomen. Standard treatment of PeM is …
that originates from the peritoneal lining of the abdomen. Standard treatment of PeM is …
[HTML][HTML] Histone methyltransferase SETD2: a potential tumor suppressor in solid cancers
R Chen, W Zhao, C Fang, X Yang, M Ji - Journal of Cancer, 2020 - ncbi.nlm.nih.gov
Epigenetic regulation plays an important role in the occurrence, development and treatment
of malignant tumors; and a great deal of attention has been paid to the histone methylation …
of malignant tumors; and a great deal of attention has been paid to the histone methylation …
[HTML][HTML] Well-differentiated papillary mesothelioma of the peritoneum is genetically defined by mutually exclusive mutations in TRAF7 and CDC42
M Stevers, JT Rabban, K Garg, J Van Ziffle, C Onodera… - Modern Pathology, 2019 - Elsevier
Well-differentiated papillary mesothelioma is an uncommon mesothelial neoplasm that most
frequently arises in the peritoneal cavity of women of reproductive age. Whereas malignant …
frequently arises in the peritoneal cavity of women of reproductive age. Whereas malignant …
[HTML][HTML] Malignant peritoneal mesothelioma: clinical aspects, and therapeutic perspectives
Malignant peritoneal mesothelioma (MPM) is a rare disease with a wide clinical spectrum. It
arises from the peritoneal lining and commonly presents with diffuse, extensive spread …
arises from the peritoneal lining and commonly presents with diffuse, extensive spread …
Malignant pleural mesothelioma: an update
Malignant mesotheliomas are rare types of cancers that affect the mesothelial surfaces,
usually the pleura and peritoneum. They are associated with asbestos exposure, but due to …
usually the pleura and peritoneum. They are associated with asbestos exposure, but due to …
Well differentiated papillary mesothelial tumor: a new name and new problems
A Churg, F Galateau-Salle - Modern Pathology, 2022 - nature.com
Well-differentiated papillary mesothelial tumor (WDPMT, formerly called well-differentiated
papillary mesothelioma) is a morphologically distinctive lesion composed of expansile …
papillary mesothelioma) is a morphologically distinctive lesion composed of expansile …
Ubiquitin carboxyl-terminal hydrolases: involvement in cancer progression and clinical implications
Y Fang, X Shen - Cancer and Metastasis Reviews, 2017 - Springer
Protein ubiquitination and deubiquitination participate in a number of biological processes,
including cell growth, differentiation, transcriptional regulation, and oncogenesis. Ubiquitin C …
including cell growth, differentiation, transcriptional regulation, and oncogenesis. Ubiquitin C …